Lotus Pharmaceuticals, Inc. engages in the manufacture and distribution of pharmaceutical products in the People's Republic of China. The company is headquartered in Beijing, Beijing and currently employs 233 full-time employees. The company went IPO on 2012-05-15. The firm produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The firm's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The firm operated in two business segment Wholesales segment and Retail segment. The firm's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The firm mainly conducts its businesses in the domestic market and overseas markets.
Lotus Pharmaceuticals Inc (LTUS) Chart
Financial Metrics & Statements of Lotus Pharmaceuticals Inc (LTUS)
FAQ's for Lotus Pharmaceuticals Inc (LTUS)
As of August 2026, Lotus Pharmaceuticals Inc LTUS is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lotus Pharmaceuticals Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Lotus Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Lotus Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Lotus Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Lotus Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Lotus Pharmaceuticals Inc (LTUS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.